FDA Advisers Deliberate the Future of ‘Artificial Womb’ Technology for Human Infants
FDA Advisers Deliberate the Future of ‘Artificial Womb’ Technology for Human Infants In a historic meeting that brought together a panel of experts convened by the U.S. Food and Drug Administration (FDA), the future of ‘artificial womb’ technology for human infants took center stage. This visionary concept, once relegated to the realm of science fiction,…